These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatocellular carcinoma: harmonic ultrasound and contrast agent. Kim TK; Kim AY; Choi BI Abdom Imaging; 2002; 27(2):129-38. PubMed ID: 11847572 [No Abstract] [Full Text] [Related]
3. Three-dimensional power Doppler imaging in depicting vascularity in hepatocellular carcinoma. Xu HX; Liu L; Lu MD; Li HP; Liu GJ; Li JP J Ultrasound Med; 2003 Nov; 22(11):1147-54. PubMed ID: 14620884 [TBL] [Abstract][Full Text] [Related]
4. Three-dimensional power Doppler ultrasonography for hepatocellular carcinoma: a comparison with angiography? Sato S; Yoshida H; Teratani T; Obi S; Koike Y; Shiina S; Omata M Hepatogastroenterology; 2005; 52(61):72-5. PubMed ID: 15782997 [TBL] [Abstract][Full Text] [Related]
5. Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities. Gaiani S; Casali A; Serra C; Piscaglia F; Gramantieri L; Volpe L; Siringo S; Bolondi L Am J Gastroenterol; 2000 Dec; 95(12):3537-46. PubMed ID: 11151890 [TBL] [Abstract][Full Text] [Related]
8. [FFT analysis of blood flow in hepatocellular carcinoma]. Tochio H; Okabe Y Nihon Rinsho; 2001 Oct; 59 Suppl 6():258-63. PubMed ID: 11761951 [No Abstract] [Full Text] [Related]
9. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Lencioni R; Pinto F; Armillotta N; Bartolozzi C Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222 [TBL] [Abstract][Full Text] [Related]
11. [Contrast enhanced power Doppler in evaluating the angiogenesis in hepatocellular carcinoma]. Xiao JD; Shen SR; Li RZ; Zhou P; Zhu WH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):840-4. PubMed ID: 18007081 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional power Doppler ultrasonography for demonstrating associated arteries of hepatocellular carcinoma. Liang JD; Yang PM; Liang PC; Huang GT; Sheu JC; Chen DS J Formos Med Assoc; 2003 Jun; 102(6):367-74. PubMed ID: 12923588 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy. Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917 [TBL] [Abstract][Full Text] [Related]
16. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging. Wilson SR; Burns PN Semin Liver Dis; 2001 May; 21(2):147-59. PubMed ID: 11436569 [TBL] [Abstract][Full Text] [Related]
17. [Is US angiography (USAG) still a gold-standard in the diagnosis of hepatocellular carcinoma]. Takeuchi F; Horiguchi Y; Kubo H; Suzuki R; Fujita H; Nishikawa T Nihon Rinsho; 2001 Oct; 59 Suppl 6():248-53. PubMed ID: 11761948 [No Abstract] [Full Text] [Related]
18. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236 [TBL] [Abstract][Full Text] [Related]